Research map: Risk stratification of voriconazole-induced hepatotoxicity through therapeutic drug monitoring combined with the albumin–bilirubin score: a multicenter retrospective cohort study in Japan

Back to the article

Papers in this map

  1. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America · Thomas F. Patterson · 2016 · 2933 citations · Cited by this paper
  2. Machine learning-based drug susceptibility prediction from Candida genomic data · 2026 · Related
  3. Global incidence and mortality of severe fungal disease · David W. Denning · 2024 · 1558 citations · Cited by this paper
  4. Emergence of dalbavancin non-susceptible methicillin-resistant Staphylococcus epidermidis (MRSE) in a patient treated with dalbavancin prolonged therapy: Case report, therapeutic drug monitoring and genomic characterization · 2026 · Related
  5. Identification of the Cytochrome P450 Enzymes Involved in the N-Oxidation of Voriconazole · Ruth Hyland · 2003 · 383 citations · Cited by this paper
  6. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacterales bacteraemia in high-risk neutropenic patients in haematology: A multicentre retrospective study · 2026 · Related
  7. Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring · Michael J. Dolton · 2012 · 292 citations · Cited by this paper
  8. An exploratory pharmacokinetic-pharmacodynamic analysis of ceftazidime-avibactam and various blood biomarkers in patients with hospital-acquired pneumonia or ventilator-associated pneumonia caused by Klebsiella pneumoniae · 2026 · Related
  9. Practice guidelines for therapeutic drug monitoring of voriconazole: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring · Yukihiro Hamada · 2013 · 249 citations · Cited by this paper
  10. Vancomycin penetration into intra-abdominal compartments: Site concentration disparities and implications for dose optimization in gram-positive infections · 2026 · Related
  11. Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis · Haiying Jin · 2016 · 175 citations · Cited by this paper
  12. Optimizing the Meropenem Dosing Regimen in Neonates: A Dual-Centre Cohort Study · 2026 · Related
  13. Voriconazole metabolism is influenced by severe inflammation: a prospective study · Anette Veringa · 2016 · 163 citations · Cited by this paper
  14. A Novel blaTMB Allele Encoding a Functional Carbapenemase Associated with a Gamma-Mobile-Trio Island · 2026 · Related
  15. Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity · Dimitra Mitsani · 2012 · 132 citations · Cited by this paper
  16. Ecr positively regulates activity of the PhoQ/PhoP signalling system in Klebsiella pneumoniae · 2026 · Related
  17. Clinical Practice Guideline for the Therapeutic Drug Monitoring of Voriconazole in Non-Asian and Asian Adult Patients: Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring · Yoshio Takesue · 2022 · 87 citations · Cited by this paper
  18. Broad-spectrum empirical antibiotic overuse in community-onset bacteraemia: Prevalence, outcomes, and associated factors · 2026 · Related
  19. Hepatic Manifestations in Hematological Disorders · Jun Murakami · 2013 · 79 citations · Cited by this paper
  20. Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity · Yosuke Suzuki · 2013 · 68 citations · Cited by this paper
  21. Mortality in chronic pulmonary aspergillosis: a systematic review and individual patient data meta-analysis · Abhinav Sengupta · 2024 · 58 citations · Cited by this paper
  22. Evaluation of the effect of obesity on voriconazole serum concentrations · Elizabeth Koselke · 2012 · 56 citations · Cited by this paper
  23. Therapeutic drug monitoring and safety of voriconazole therapy in patients with Child–Pugh class B and C cirrhosis: A multicenter study · Taotao Wang · 2018 · 56 citations · Cited by this paper
  24. Voriconazole therapeutic drug monitoring and hepatotoxicity in critically ill patients: A nationwide multi-centre retrospective study · Taotao Wang · 2022 · 39 citations · Cited by this paper
  25. Voriconazole-induced photocarcinogenesis is promoted by aryl hydrocarbon receptor-dependent COX-2 upregulation · Shigeki Ikeya · 2018 · 38 citations · Cited by this paper
  26. Sex disparity and drug-induced liver injury · Annarosa Floreani · 2022 · 38 citations · Cited by this paper
  27. Drug-induced liver injury associated with high-dose ceftriaxone: a retrospective cohort study adjusted for the propensity score · Kazuhiko Nakaharai · 2016 · 37 citations · Cited by this paper
  28. Metabolomics Investigation of Voriconazole-Induced Hepatotoxicity in Mice · Shin-Lun Wu · 2019 · 30 citations · Cited by this paper
  29. A Risk Prediction Flowchart of Vancomycin-Induced Acute Kidney Injury to Use When Starting Vancomycin Administration: A Multicenter Retrospective Study · Takayuki Miyai · 2020 · 30 citations · Cited by this paper
  30. Metabolic Disorders Are Associated With Drug-Induced Liver Injury During Antituberculosis Treatment: A Multicenter Prospective Observational Cohort Study in Korea · Jihye Lim · 2023 · 20 citations · Cited by this paper
  31. Risk evaluation of carbapenem-induced liver injury based on machine learning analysis · Yuki Asai · 2023 · 14 citations · Cited by this paper
  32. The epidemiological characteristics of invasive pulmonary aspergillosis and risk factors for treatment failure: a retrospective study · Yun Wang · 2024 · 12 citations · Cited by this paper
  33. Machine Learning-Based Prediction of Digoxin Toxicity in Heart Failure: A Multicenter Retrospective Study · Yuki Asai · 2023 · 11 citations · Cited by this paper
  34. Optimal timing for therapeutic drug monitoring of voriconazole to prevent adverse effects in Japanese patients · Yuki Hanai · 2023 · 10 citations · Cited by this paper
  35. Association of BMI with mortality in drug-induced liver injury · Zikun Ma · 2023 · 8 citations · Cited by this paper
  36. Voriconazole-induced liver injury: incidence patterns and risk factors in a retrospective cohort · Yan Lou · 2025 · 8 citations · Cited by this paper
  37. Potential of Albumin-Bilirubin Score for Estimating the Voriconazole-Induced Hepatotoxicity Undergoing Therapeutic Drug Monitoring: A Single-Center Retrospective Cohort Study · Yuki Asai · 2025 · 7 citations · Cited by this paper
  38. Voriconazole-Induced Hepatotoxicity Concise up-to-date review · Özge Ertem · 2022 · 5 citations · Cited by this paper
  39. Decreased Hepatic Functional Reserve Increases the Risk of Piperacillin/Tazobactam-Induced Abnormal Liver Enzyme Levels: A Retrospective Case-Control Study · Hayahide Ooi · 2024 · 5 citations · Cited by this paper

Source: OpenAlex (CC0)